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Abstract: Many steps in the baculovirus life cycle, from initial ingestion to the subsequent infection
of all larval cells, remain largely unknown; primarily because it has hitherto not been possible to
follow individual genomes and their lineages. Use of ANCHORTM technology allows a high intensity
fluorescent labelling of DNA. When applied to a virus genome, it is possible to follow individual
particles, and the overall course of infection. This technology has been adapted to enable labelling of
the baculovirus Autographa californica Multiple NucleoPolyhedroVirus genome, as a first step to
its application to other baculoviruses. AcMNPV was modified by inserting the two components of
ANCHORTM: a specific DNA-binding protein fused to a fluorescent reporter, and the corresponding
DNA recognition sequence. The resulting modified virus was stable, infectious, and replicated
correctly in Spodoptera frugiperda 9 (Sf9) cells and in vivo. Both budded viruses and occlusion bodies
were clearly distinguishable, and infecting cells or larvae allowed the infection process to be monitored
in living cells or tissues. The level of fluorescence in the culture medium of infected cells in vitro
showed a good correlation with the number of infectious budded viruses. A cassette that can be
used in other baculoviruses has been designed. Altogether our results introduce for the first time the
generation of autofluorescent baculovirus and their application to follow infection dynamics directly
in living cells or tissues.
Keywords: real-time imaging; fluorescence labelling; baculovirus infection
1. Introduction
Baculoviruses are viruses specific to arthropods. Their genome consists of a single circular
double-stranded DNA molecule that ranges in size from 80 to 200 kb. In the field, baculovirus
transmission is mainly via the oral route. During infection, baculoviruses produce two dierent virions
Viruses 2020, 12, 50; doi:10.3390/v12010050 www.mdpi.com/journal/viruses
Viruses 2020, 12, 50 2 of 11
that contain identical genomes but dier in their structure and function. The budded virus (BV) is
involved in systemic infection (cell-to-cell infection) within the host [1]. In the occlusion body (OB),
the virions are embedded in a proteinaceous matrix, where the major component is a virus-encoded
protein called polyhedrin or granulin, according to the virus considered. OBs are responsible for the
transmission between hosts, via the environment. From a taxonomic perspective, the Baculoviridae
family is presently composed of four genera, Alphabaculovirus, Gammabaculovirus, and Deltabaculovirus,
whose OBs contain polyhedrin and embed many virions. In contrast, the Betabaculovirus have smaller
OBs that contain only one virion within a granulin matrix [2]. During the infection cycle, infected cells
usually produce both virus particle types in a sequential way, first the BVs, then the OBs.
Baculoviruses are widely used as biological control agents and as heterologous protein expression
systems. The success of baculoviruses as biological control agents relies on the fact that the range of
each virus species is usually restricted to a very limited number of hosts, they have no side eect on the
environment and are safe for human health [3]. Examples of control of insect pests with baculoviruses
are the use of Anticarsia gemmatalis multiple nucleopolyhedrovirus (AgMNPV, Alphabaculovirus)
in Brazil to control the velvetbean caterpillar on soybean [4] or the Cydia pomonella granulovirus
(CpGV, Betabaculovirus) to control codling moth on apple and pear trees [5]. Analysis of the factors
involved in host range determination requires following each step of the infection process both at the
cellular level and at the whole insect level. As the production of OBs is not required for survival in
cell culture, in the early 1980s the high level of expression of the polyhedrin gene attracted attention
for biotechnology applications [6,7], leading to the generalization of baculoviruses as expression
systems [8]. Baculoviruses are common tools in many areas of biotechnology [9], mainly for the
production of proteins, both in cell culture or in insect larvae [10]. Modifying the regulation of virus
gene expression allows modulating the quantity and the post-translational modifications of the foreign
proteins expressed [11].
Many dierent approaches have contributed to today’s comprehension of the baculovirus lifecycle.
Among them, the inclusion of an easy-to-recognize marker in the virus genome has allowed the
identification of infected cells when the marker is expressed. Fluorescent markers like green fluorescent
protein (GFP) variants have been extensively used. Labelling the virus particles (chemically or by the
use of fusion proteins) permit following the entry or the egress of the virus from the cell. However,
these two approaches have limitations. Expression in the infected cell requires the activation of the
virus cycle, which does not allow following the early steps of infection. Labelling the structural proteins
of the virus usually yields a low level signal, and does not allow following the virus cycle between
uncoating and virus egress.
The ANCHOR technology is based on a bacterial genetic element, the parABS system, which
allows segregation and plasmid partition [12,13]. The parABS system is composed of: parA (ATPase
activity), parB (DNA-binding protein) and parS (cis acting DNA sequence). An ANCHOR cassette
contains both one ANCH target sequence (which comes from parS) and the gene encoding the
corresponding OR protein (which is the parB protein), fused to a fluorescent protein, like GFP; OR-GFP
binds to DNA that carries ANCH sequences. Once a stable ANCH/OR-GFP binding is established,
a multimerization process occurs, and up to 500 molecules of OR-GFP can bind to the same DNA
molecule. Such multimerization results in a signal amplification that allows detection of the target
DNA (Figure 1) [14]. ANCHOR systems have been used successfully to analyze motion of single
genomic loci and DNA double-strand break processing in living yeast [15], or for the assessment of
the eect of Ganciclovir on human cytomegalovirus HCMV [16], adenovirus infection and biphasic
genome replication [17], and chromatin dynamics during transcription in human cells [14].
In this paper, as a proof of concept, we adapted ANCHOR3 DNA labeling technology for
the tracking of Autographa calinornica Multiple Nucleopolyhedrovirus (AcMNPV) in living cells
(Figure 1). First, we created a viral AcMNPV genome containing both the ANCH target sequence and
the gene encoding the corresponding OR-GFP protein at two separate loci (AcMNPV1–ANCHOR3).
We have verified that the virus obtained is viable, that the fluorescence is high enough to follow a
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single virus particle, and that it is proportional to the number of particles. Then, we constructed a
cassette containing all ANCHOR3 components in a single plasmid at one genome location. This
approach allows for generating recombinant viruses in a single step. In addition, it opens the way for
an easy adaptation of this technology to other baculoviruses.
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Figure 1. (a) Construction and function of the AcMNPV1–ANCHOR3 virus contai ing both ANCH3
and OR3-GFP. (b) Schematic to show function of a ANCHOR3 virus. (1) OR3-GFP expression; (2)
OR3-GFP binding to ANCH3 sequence (up to 500 particles per ANCH3 site); (3) Excitation of viral
DNA containing ANCHOR3 cassette at 485 nm; (4) Light emi sion at 535 nm.
2. Materials and Methods
2.1. Virus and Cells
A modified AcMNPV was used as a base for the constructs [18]. All final constructs retain the
polh gene, allowing a positive selection by the presence of occlusion bodies and infectivity for larvae.
Spodoptera frugiperda 9 (Sf9) cells (ATCC # CRL1711) [19] were cultured in the laboratory using
previously published conditions [19], at 28 C in TC100 medium supplemented with 5% FBS, 0.5%
penicillin-streptomycin and 1% pluronic acid.
2.2. Construction of Baculovirus Transfer Vectors
All plasmid constructions were carried out and amplified in E. coli XL1 blue bacteria. For the
first proof of concept, the two components of the ANCHOR3TM system (provided by NeoVirTech,
Toulouse, France) were used. They were obtained from plasmids pANCH3 and OR3GFP, by PCR
amplification (Vent® DNA Polymerase, New England Biolabs, Ipswich, MA, USA) of the specific
sequences using primers that provide the appropriate cloning restriction sites. The fragment containing
the ANCH sequences (982 bps) was amplified and inserted into pGmAc116T [20] between EcoRV and
KpnI at the polh locus. The or3-gfp fusion gene-coding sequences (coding the corresponding protein
which specifically binds the ANCH3 sequence), fused to gfp, (Figure 1) (1786 bps) were amplified
using primers providing the appropriate cloning restriction sites. The fragment was inserted into
pUC-AD20 (pUC-prA3-stA3) [21] between EcoRI and MfeI. To allow continuous expression of the
gene upon baculovirus infection of cells, this fragment was inserted downstream of the Bombyx mori
A3 promoter (prA3) and upstream A3 stop (StA3) (GenBank accession number U49854). The whole
cassette containing the A3 promoter, the or3-gfp fusion gene, and the A3 terminator was excised with
XbaI and inserted into the baculovirus transfer vector pVT/gp37, at the gp37 locus [22]. All constructs
were verified by their restriction profiles. Both transfer vector DNAs were purified using NucleoBond®
Xtra Midi (Macherey-Nagel, Hoerdt, France).
For the construction of a single plasmid cassette, both components of ANCHOR3TM were
inserted in the pAcUW2B transfer vector [23], by substituting the p10 promoter moiety by the
prA3-or3-gfp-A3term cassette, then, the ANCH3 sequences were inserted at the EcoRV site located
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upstream of the polh promoter. pAcUW2B retains the polh gene, allowing a positive selection when
co-transfecting with Dpolh virus DNA.
2.3. Construction of Recombinant AcMNPV–ANCHOR3 Baculovirus
AcMNPV1–ANCHOR3 was constructed by inserting the two components of the system
via homologous recombination between the parental virus DNA and the two transfer vectors
pGmAc116T-ANCH3 and pVT/gp37-OR3. These inserts were placed in the baculovirus genome
at the polh and at the gp37 genes (Ac ORF 64), respectively [22] (Figure 2).
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Figure 2. AcMNPV2–ANCHOR3 construction. Both components of the ANCHOR3 system were
inserted into a single transfer vector based on pAcUW2B, where the p10 promoter region was substituted
by the A3-OR3-GFP-STA3. The OR3-GFP sequences were inserted between the polh gene and the A3
promoter, at the EcoRV site.
Co-transfection was carried out using Sf9 cells and DOTAP
(N-[1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfate) as transfection
agent. Recombinant viruses, that are fluorescent upon UV light and POLH+ were then selected by
plaque assay to obtain pure virus stocks, and then amplified to high titers (2  107 plaque forming
units PFU/mL) in Sf9 cells. These stocks were stored at 4 C. The virus titer was determined by plaque
assay [24].
AcMNPV2–ANCHOR3 was obtained by co-transfecting pAcUW2B–ANCHOR3 with BacPAK6, a
parental virus DNA [25]. Recombinants at the polh region were selected by their POLH+ phenotype
and by their fluorescence, using the procedure previously described.
Isolation and quantification of viruses were performed by plaque assay. Sf9 cells at 1  106
cellsmL 1 were plated into 6-well Falcon® plates, in serum-free medium supplemented with 0.5%
penicillin-streptomycin and 1% pluronic acid for one hour. The medium was then discarded. Cells
were infected with 500 L of each virus at a range of dierent concentrations, and incubated during
one hour at room temperature (RT); then the inoculum was removed. Two mL of medium with 1%
(w/v) of agarose was added into each well, the plates were then incubated for five days at 28 C [24].
2.4. Spodoptera Exigua Infection
S. exigua eggs were provided by P. C ballero, Univ rsidad Pública de Navarra, and reared on
artificial diet (Stonefly Heliothis diet. Ward’s Science, Rochester, NY, USA). S. exigua larvae (seven
days old) were fed with OBs obtained from cell culture by spreading the cellular pellet that contains
OBs ont the diet.
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2.5. Fluorescence Imaging and Quantification
Live microscopy was performed as previously described [16] using a Zeiss Axiovert Observer Z1.
Sf9 cells infected with AcMNPV1-ANCHOR3 were observed using a 63 objective. Image analysis was
performed using Fiji software. Visualization of the S. exigua larva infected by recombinant AcMNPV
was carried out using a 10 objective.
Fluorescence quantification was performed using 96-well, black flat-bottom plates filled with 100
L of supernatant of infected cell culture at various times post-infection, using as control supernatant
of wildtype (Wt) AcMNPV infected cells. In parallel, each sample titer was determined by plaque assay
as indicated previously. The excitation wavelength used was 485 nm and the emission wavelength
was 530 nm (bandwidth 20 nm for both). The intensity of fluorescence was measured in triplicate on a
fluorescence reader Tecan Spark 10M microplate reader using SparkControl V1.2.20 software.
3. Results
3.1. Construction of AcMNPV–ANCHOR3 Viruses
In a first approach, the two components of the ANCHOR3TM system were inserted at two dierent
loci in the AcMNPV genome, to avoid putative interferences. Co-transfection of the parental AcMNPV
bacmid DNA and the transfer vectors containing the two components of the ANCHORTM system
allowed the recovery of recombinant dual viruses that were cloned by plaque purification (Figure 1).
The clones obtained were checked by their fluorescence ability, and the insertions were verified by
PCR. A second approach was then used to prepare a single cassette allowing the insertion of both
components at the same locus (Figure 2). This second virus AcMNPV2–ANCHOR3 behaves similarly
to the first; no dierences were observed between the two viruses.
3.2. Structural and Biological Characterisation of AcMNPV–ANCHOR Virus
The association of a high number (up to 500 copies) of the OR3-GFP fusion protein to the virus
genome could interfere with virus nucleocapsid structure. Therefore, the structure of the virions has
been analyzed by electron microscopy. No dierences could be observed in the overall structure of the
virions (Supplementary Figure S1).
The replication of AcMNPV1-ANCHOR3 virus was observed in vitro and in vivo. Sf9 cells and S.
exigua larva were infected with the recombinant virus. No delay was observed in the formation of
OBs. Observation of the infected cells under fluorescence microscopy confirmed that abundant OBs
were produced, and that the fluorescence was concentrated in the OBs, resulting in a characteristic
“spotty” appearance (Figure 3a). The fluorescence present in a diuse form in the cytoplasm is due to
the expression of the OR3-GFP protein, that later migrates to the nucleus and condenses with ANCH3
containing virus DNA. At early stages of infection, it is possible to see brilliant spots of fluorescence
in the cytoplasm or in the cytoplasmic membrane that correspond to nucleocapsid migration and
budded virus egress. The infection of culture cells could be followed under microscope, although the
amplitude of the fluorescence variation did not allow a single parameter setting for the whole infection
time course (see movie S1 in supplementary material for late times of infection). OBs were used to
orally infect third instar (seven days old) S. exigua larvae. Forty-eight hours post-infection (hp.i.), the
living larvae were observed under a confocal fluorescence microscope. Infection of the tissues was
observed, particularly at the level of the tracheal epithelium (Figure 3b,c). Even though the larval
cuticle shows autofluorescence with the excitation/emission filters used, the presence of fluorescent
particles in the midgut and the tracheal tissues can be observed.
A one-step growth experiment was carried out with wild-type and recombinant viruses (Figure 4).
A slightly lower rate of replication and a lower final titer of BV was obtained for recombinant viruses.
The final titer for AcMNPV1-ANCHOR3 was 1.24  107 OBs/mL compared to 2.07  107 OBs/mL for
AcMNPV-Wt. Comparable results were obtained for AcMNPV2-ANCHOR3.
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passages A3, A4, and A5 for both viruses were measur d by plaque assay (Table 1); me n and standard
deviation (SD) are also sho n. The titer of AcMNPV–Wt w s always slightly higher than that of
AcMNPV1–ANCHOR3, in accordance with the results obtained in t e growth experiment.
Table 1. Titers obtained by plaque assay of dierent passages (Ai) for AcMNPV–Wt and AcMNPV1–ANCHOR.
Virus A3 A4 A5 Mean SD
AcMNPV–Wt 5.80  107 9.10  106 1.93  107 2.88  107 2.58  107
AcMNPV1–ANCHOR3 2.42  107 3.12  106 1.27  107 1.33  107 1.06  107
3.3. Real-time Visualization of AcMNPV–ANCHOR
The infection of Sf9 cells by AcMNPV1–ANCHOR3 was followed under a fluorescence microscope
with a time lapse of 30 min from 0 to 17 hp.i and 10 min from 21 h p.i. to 42 h p.i. The size of a BV
particle is at the limit of the resolution of the microscope and thus appears as a single pixel. Specific
infection events were captured: nucleocapsids migrating through the cytoplasm, BV budding out of
the cell, progeny virus labeled in culture medium, and OBs production in the nucleus (Figure 5).
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The relationship between the number of BVs released into the culture medium and the level of 
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Representative images of the infection cycle are presented in Figure 6. Due to the high variation
in the fluorescence level, it was not possible to obtain the hole virus cycle with a single experiment
as the exposure length needed to be reduced at later times of infection. The early infection steps (6
hp.i. to 8 hp.i.) are shown in Figure 6a. New progeny viruses labelled with ANCHOR3 appeared as
fluorescent spots at 6.5 hp.i. in the nucleus, but it was possible to see BV migration in the cytoplasm as
single spots. The number of spots in the nucleus increased with time.
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The later steps of infection are shown in Figure 6b. At 28 hp.i., multiple OBs were visible, but
considerable amounts of uncondensed fluorescence were also present in the nucleus. They correspond
to virus genomes that have not been encapsidated. At 29 hp.i., cells became detached, started to expand,
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and fluorescence looked more diuse. After 32 hp.i., the cells were dead and free or aggregated OBs
were dispersed in the culture medium.
3.4. Budded Virus Quantification by Fluorimetry
The relationship between the number of BVs released into the culture medium and the level of
fluorescence was analyzed at 0, 8, 16, 24, 36, 48, 72, and 96 hp.i. Relative fluorescence unit (RFU) was
plotted versus infection time (Figure 7a). Fluorescence of AcMNPV–Wt was used as a negative control
and subtracted from recombinant viruses. In Figure 7a, the RFU from 0 hp.i. to 16 hp.i. follows a lag
phase, then enters into an exponential phase until 48 hp.i., which marks the stationary phase.
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In order to determine the link between RFU of AcMNPV1–ANCHOR3 and the viral concentration,
RFU were plotted versus virus titers obtained by plaque assay (Figure 7b). A correlation of R2 = 0.98
was obtained. This linearity indicates that the fluorimetric reading can be utilized as a quantitative
method. The limit of detection (LoD) of the fluorimetric reading method was around 50 BVs, while 1
BV could be identified by microscopy.
4. Discussion
Understanding the process of infection at the cellular level within insect is one of the barriers
that prevent further understanding of the progress of the infection and the defe se barri rs that the
insect raises against the virus.
The approaches that are available to the scientific community to address this problem has
diversified with time; from the original pathology observations [26] through the modern pathology
and histological studies [27], it has been possible to describe the progressive modification of the larval
organs. The development of electron microscopy has allowed studying specific steps in the virus/host
relationships. Multiple images of virus binding to cells, or nucleocapsid migration from the nucleus
through the cell cytoplasm and budding from the cellular membrane, has allowed reconstruction of
the temporal process.
Chemical labelling f the virus particles, or detection of these particles with immunolabelling, has
permitted capturi g views of specific processes, while the use of modified viruses expressing marker
genes has allowed identification of infections spreading from one cell to another. One of the limits of
all available techniques is, however, the impossibility of following the infection process of a single
genome in living cells, from virus entry to the nucleus, to the ospring virus genomes packaging into
progeny viruses.
To that aim, labeling the DNA in a specific way becomes necessary. The development of the
ANCHORTM technology, based on the bacterial parABS partition system, appeared as an attractive
way to attain this goal. The labelling using this approach results i the virus D A being covered
with a relatively high number of OR-GFP proteins. In previ us work [14], it has been estima ed that
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the ANCH3 cassette induces the polymerization of up to 500 copies of the OR3-GFP protein. As the
baculovirus genome is tightly associated with the P6.9 basic protein and packed into the nucleocapsid
mainly constituted of VP39, it was important to assess whether the presence of such proteins would
interfere with the virus assembly and thus with the virus infectivity. In addition, the ability of these
particles filled with OR3-GFP proteins to occlude into OBs required specific tests. An AcMNPV virus
carrying ANCH3 upstream of the polh locus and OR3-GFP in lieu of gfp37 was constructed. Under
scanning electron microscopy, no dierences were observed between AcMNPV1-ANCHOR3 and the
wild-type virus either at the level of the nucleocapsids, or on the global OB structure. The infectivity of
the recombinant viruses was tested both for BV in cell culture and for OBs in larva, on a per os infection
using S. exigua. A small decrease in the final titer obtained in cell culture was observed.
The recombinant AcMNPV1–ANCHOR3 virus appears to be stable at least during six successive
passages in vitro, suggesting that the bacterial sequences do not suer from strong selection in the
insect system. These results confirm other results showing that a 109 amplification of an HCMV
ANCHORTM virus still leads to the production of 93% of ANCHORTM tagged viruses in vitro [16].
AcMNPV1–ANCHOR3 was used to follow the cycle of infection in Sf9 cells. The size of the BV, 200
nm  100 nm, is too small to be resolved by light microscopy. However, the intensity of the fluorescence
emission by a single particle was sucient to be detected as a single pixel by our microscope. It was
possible to follow the first contact with the cell, and the internalization of the virus particle.
At early times of infection, the development of the viral stroma can be observed as a diuse
fluorescence, followed soon by more intense zones probably corresponding to the viral factories [28].
These authors indicate that the number of points of DNA replication would be about 15. We observe
about this number (Figure 6).
At late times of infection, many bright spots fill the entire nucleus of the infected cell that
correspond to the OBs. It should be noted that there is fluorescence outside these OBs, confirming that
baculovirus DNA is present in a free form in the nucleus, as previously observed by Vanarsdall et
al. [29], which estimated that only about 28% of the viral DNA synthesized was encapsidated into the
OBs. The green halo in the cytoplasm is due to the reflection of fluorescence from the nucleus, and not
to a high level of OR3-GFP in the cytoplasm. In fact, almost all OR3-GFP is translocated to the nucleus.
The linearity between the fluorescence level and the BV titer suggests that all virus particles
are equally decorated by the OR3-GFP protein, and that expression under the B. mori A3 promoter
was sucient.
To facilitate future use of the ANCHORTM system in other baculoviruses, a single cassette
containing both components, OR3-GFP and ANCH3, was constructed and a recombinant virus,
AcMNPV2–ANCHOR3, was produced. This virus behaves similarly to AcMNPV1–ANCHOR3.
In conclusion, it has been possible to adapt the ANCHOR system to the baculovirus. By labelling
the virus DNA as soon as it is synthesized, it has been possible to follow a virus particle and its
ospring in an infected cell or in a whole larva. This approach opens the way to study the blocking
points in resistant insects, or the outcomes in mixed infections.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/1/50/s1,
Video S1. Time lapse film of AcMNPV1-ANCHOR3 infecting Sf9 cells; Figure S1. Electron microscopy observations
of AcMNPV1-ANCHOR3 (a) Scanning electron microscopy of OBs and (b) Transmission electron microscopy
of ODVs.
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